The pathogenesis of pulmonary fibrosis: a moving target
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is characterised by excessive matrix formation leading to destruction of the normal lung architecture and finally death. Despite an exponential increase in our understanding of potentially important mediators and mechanisms, the delineation of primary pathways has proven to be elusive. In this review susceptibility and injurious agents, such as viruses and gastro-oesophageal reflux, and their probable role in initiating disease will be discussed. Further topics that are elaborated are candidate ancillary pathways, including immune mechanisms, oxidative and endoplasmic reticulum stress, activation of the coagulation cascade and the potential role of stem cells. This review will try to provide the reader with an integrated view on the current knowledge and attempts to provide a road map for future research. It is important to explore robust models of overall pathogenesis, reconciling a large number of clinical and scientific observations. We believe that the integration of current data into a “big picture” overview of fibrogenesis is essential for the development of effective antifibrotic strategies. The latter will probably consist of a combination of agents targeting a number of key pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
THE MAMMALIAN UNFOLDED PROTEIN RESPONSE
Schröder, M., & Kaufman, R. J. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074134 · Cited by 3,026
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,445
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
Willis, B. C., & Borok, Z. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00163.2007 · Cited by 1,042
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042976 · Cited by 964
Self-citationGross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
A Mutation in the Surfactant Protein C Gene Associated with Familial Interstitial Lung Disease
Nogee, L. M., Dunbar, A. E., Wert, S. E., Askin, F., Hamvas, A., & Whitsett, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440805 · Cited by 929
Pusztaszeri, M. P., Seelentag, W., & Bosman, F. T. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6514.2005 · Cited by 865
Transforming growth factor-beta: recent progress and new challenges.
Sporn, M. B., & Roberts, A. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.5.1017 · Cited by 769
Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance
Katzenstein, A.-L. A., & Fiorelli, R. F. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199402000-00003 · Cited by 755
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
Raghu, G., Freudenberger, T. D., Yang, S., Curtis, J. R., Spada, C., Hayes, J., Sillery, J. K., Pope, C. E., & Pellegrini, C. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00037005 · Cited by 643
Thomas, A. Q., Lane, K., Phillips, J., Prince, M., Markin, C., Speer, M., Schwartz, D. A., Gaddipati, R., Marney, A., Johnson, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200112-123oc · Cited by 641
Zuo, F., Kaminski, N., Eugui, E., Allard, J., Yakhini, Z., Ben-Dor, A., Lollini, L., Morris, D., Kim, Y., DeLustro, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092134099 · Cited by 620
Idiopathic Nonspecific Interstitial Pneumonia: Report of an American Thoracic Society Project
Travis, W. D., Hunninghake, G., King, T. E., Lynch, D. A., Colby, T. V., Galvin, J. R., Brown, K. K., Chung, M. P., Cordier, J.-F., du Bois, R. M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200611-1685oc · Cited by 599
Self-citationPark, J. H., Kim, D. S., Park, I.-N., Jang, S. J., Kitaichi, M., Nicholson, A. G., & Colby, T. V. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-912oc · Cited by 597
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Kim, E. J., Elicker, B. M., Maldonado, F., Webb, W. R., Ryu, J. H., Van Uden, J. H., Lee, J. S., King, T. E., & Collard, H. R. (2010) · European Respiratory Journal · doi:10.1183/09031936.00092309 · Cited by 587
Belghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Gribbin, J., Hubbard, R. B., Le Jeune, I., Smith, C. J. P., West, J., & Tata, L. J. (2006) · Thorax · doi:10.1136/thx.2006.062836 · Cited by 576
Molecular Targets in Pulmonary Fibrosis
Scotton, C. J., & Chambers, R. C. (2007) · Chest · doi:10.1378/chest.06-2568 · Cited by 538
Self-citationRole of Epithelial Cells in Idiopathic Pulmonary Fibrosis: From Innocent Targets to Serial Killers
Selman, M., & Pardo, A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-003tk · Cited by 529
Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis
Korfei, M., Ruppert, C., Mahavadi, P., Henneke, I., Markart, P., Koch, M., Lang, G., Fink, L., Bohle, R.-M., Seeger, W., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-313oc · Cited by 514
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Moeller, A., Gilpin, S. E., Ask, K., Cox, G., Cook, D., Gauldie, J., Margetts, P. J., Farkas, L., Dobranowski, J., Boylan, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1534oc · Cited by 513
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Self-citation(1995) · PubMed · Cited by 496
Lee, H.-K., Kim, D. S., Yoo, B., Seo, J. B., Rho, J.-Y., Colby, T. V., & Kitaichi, M. (2005) · Chest · doi:10.1378/chest.127.6.2019 · Cited by 484
Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis
Sisson, T. H., Mendez, M., Choi, K., Subbotina, N., Courey, A., Cunningham, A., Dave, A., Engelhardt, J. F., Liu, X., White, E. S., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1615oc · Cited by 474
Cantin, A. M., Hubbard, R. C., & Crystal, R. G. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.2.370 · Cited by 468
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Noth, I., Anstrom, K. J., Calvert, S. B., de Andrade, J., Flaherty, K. R., Glazer, C., Kaner, R. J., & Olman, M. A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0314oc · Cited by 463
Gene Expression Profiles Distinguish Idiopathic Pulmonary Fibrosis from Hypersensitivity Pneumonitis
Selman, M., Pardo, A., Barrera, L., Estrada, A., Watson, S. R., Wilson, K., Aziz, N., Kaminski, N., & Zlotnik, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-644oc · Cited by 458
Lawson, W. E., Crossno, P. F., Polosukhin, V. V., Roldan, J., Cheng, D.-S., Lane, K. B., Blackwell, T. R., Xu, C., Markin, C., Ware, L. B., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00382.2007 · Cited by 429
DANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
Selman, M., & Pardo, A. (2001) · Respiratory Research · doi:10.1186/rr175 · Cited by 379
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370
Self-citationMiyazaki, Y., Araki, K., Vesin, C., Garcia, I., Kapanci, Y., Whitsett, J. A., Piguet, P. F., & Vassalli, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118029 · Cited by 370
Nagai, S., Kitaichi, M., Itoh, H., Nishimura, K., Izumi, T., & Colby, T. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12051010 · Cited by 339
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Konishi, K., Gibson, K. F., Lindell, K. O., Richards, T. J., Zhang, Y., Dhir, R., Bisceglia, M., Gilbert, S., Yousem, S. A., Song, J. W., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1596oc · Cited by 333
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Prasse, A., Probst, C., Bargagli, E., Zissel, G., Toews, G. B., Flaherty, K. R., Olschewski, M., Rottoli, P., & Müller-Quernheim, J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1201oc · Cited by 328
Self-citationScotton, C. J., Krupiczojc, M. A., Königshoff, M., Mercer, P. F., Lee, Y. C. G., Kaminski, N., Morser, J., Post, J. M., Maher, T. M., Nicholson, A. G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33288 · Cited by 319
Self-citationJenkins, R. G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27183 · Cited by 314
Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis
Tang, Y.-W., Johnson, J. E., Browning, P. J., Cruz-Gervis, R. A., Davis, A., Graham, B. S., Brigham, K. L., Oates, J. A., Loyd, J. E., & Stecenko, A. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2633-2640.2003 · Cited by 311
van Moorsel, C. H. M., van Oosterhout, M. F. M., Barlo, N. P., de Jong, P. A., van der Vis, J. J., Ruven, H. J. T., van Es, H. W., van den Bosch, J. M. M., & Grutters, J. C. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0953oc · Cited by 294
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern
Selman, M., Carrillo, G., Estrada, A., Mejia, M., Becerril, C., Cisneros, J., Gaxiola, M., Pérez-Padilla, R., Navarro, C., Richards, T., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000482 · Cited by 270
Waghray, M., Cui, Z., Horowitz, J. C., Subramanian, I. M., Martinez, F. J., Toews, G. B., & Thannickal, V. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2882fje · Cited by 270
Song, J. W., Do, K.-H., Kim, M.-Y., Jang, S. J., Colby, T. V., & Kim, D. S. (2009) · Chest · doi:10.1378/chest.08-2572 · Cited by 248
Watters, L. C., Schwarz, M. I., Cherniack, R. M., Waldron, J. A., Dunn, T. L., Stanford, R. E., & King, T. E. (1987) · PubMed · doi:10.1164/arrd.1987.135.3.696 · Cited by 248
Rudd, R., Haslam, P. L., & Turner-Warwick, M. E. H. (1981) · PubMed · doi:10.1164/arrd.1981.124.1.1 · Cited by 245
A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells
Wang, D., Haviland, D. L., Burns, A. R., Zsigmond, E., & Wetsel, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700052104 · Cited by 245
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
Lee, J. S., Song, J. W., Wolters, P. J., Elicker, B. M., King, T. E., Kim, D. S., & Collard, H. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00050911 · Cited by 241
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Hardie, W. D., Glasser, S. W., & Hagood, J. S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081170 · Cited by 240
Chambers, R. C., Leoni, P., Blanc-Brude, O. P., Wembridge, D. E., & Laurent, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003188200 · Cited by 233
Self-citationTanjore, H., Cheng, D.-S., Degryse, A. L., Zoz, D. F., Abdolrasulnia, R., Lawson, W. E., & Blackwell, T. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.181164 · Cited by 230
Significance of Bronchoalveolar Lavage for the Diagnosis of Idiopathic Pulmonary Fibrosis
Ohshimo, S., Bonella, F., Cui, A., Beume, M., Kohno, N., Guzman, J., & Costabel, U. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1313oc · Cited by 220
Howell, D. C. J., Johns, R. H., Lasky, J. A., Shan, B., Scotton, C. J., Laurent, G. J., & Chambers, R. C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62354-1 · Cited by 218
Self-citationSTEWART, J. P., EGAN, J. J., ROSS, A. J., KELLY, B. G., LOK, S. S., HASLETON, P. S., & WOODCOCK, A. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9807077 · Cited by 204
Self-citationChemokine/Cytokine Cocktail in Idiopathic Pulmonary Fibrosis
Agostini, C., & Gurrieri, C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-010tk · Cited by 197
Self-citationBogatkevich, G. S., Tourkina, E., Silver, R. M., & Ludwicka-Bradley, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106441200 · Cited by 196
Okuma, T., Terasaki, Y., Kaikita, K., Kobayashi, H., Kuziel, W. A., Kawasuji, M., & Takeya, M. (2004) · The Journal of Pathology · doi:10.1002/path.1667 · Cited by 189
de Lauretis, A., Veeraraghavan, S., & Renzoni, E. (2011) · Chronic Respiratory Disease · doi:10.1177/1479972310393758 · Cited by 182
Khalil, N., Xu, Y. D., O'Connor, R., & Duronio, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510441200 · Cited by 182
Derivation of Lung Epithelium from Human Cord Blood–derived Mesenchymal Stem Cells
Sueblinvong, V., Loi, R., Eisenhauer, P. L., Bernstein, I. M., Suratt, B. T., Spees, J. L., & Weiss, D. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-859oc · Cited by 181
The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis
Belperio, J. A., Dy, M., Murray, L., Burdick, M. D., Xue, Y. Y., Strieter, R. M., & Keane, M. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4692 · Cited by 177
Chambers, R. C. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707603 · Cited by 175
Self-citationAlterations in the alveolar epithelium after injury leading to pulmonary fibrosis.
Kasper, M. E., & Haroske, G. (1996) · PubMed · Cited by 174
TNF-α-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis
Zhang, K., Gharaee-Kermani, M., McGarry, B., Remick, D., & Phan, S. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.954 · Cited by 170
Triggering the Induction of Myofibroblast and Fibrogenesis by Airway Epithelial Shedding
Morishima, Y., Nomura, A., Uchida, Y., Noguchi, Y., Sakamoto, T., Ishii, Y., Goto, Y., Masuyama, K., Zhang, M. J., Hirano, K., et al. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.1.4040 · Cited by 168
Egan, J. J., Stewart, J. P., Hasleton, P. S., Arrand, J. R., Carroll, K. B., & Woodcock, A. A. (1995) · Thorax · doi:10.1136/thx.50.12.1234 · Cited by 166
Self-citationLung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.
Zhang, K., Gharaee-Kermani, M., Jones, M. L., Warren, J. S., & Phan, S. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4733 · Cited by 165
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Veeraraghavan, S., Latsi, P. I., Wells, A. U., Pantelidis, P., Nicholson, A. G., Colby, T. V., Haslam, P. L., Renzoni, E. A., & du Bois, R. M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00105202 · Cited by 160
Self-citationMetalloproteinases in idiopathic pulmonary fibrosis
Dancer, R. C. A., Wood, A. M., & Thickett, D. R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00024711 · Cited by 157
Chambers, R. C., Dabbagh, K., McAnulty, R. J., GRAY, A. J., Blanc‐Brude, O., & Laurent, G. J. (1998) · Biochemical Journal · doi:10.1042/bj3330121 · Cited by 155
Self-citationPathogenesis and Natural History of Usual Interstitial Pneumonia
Strieter, R. M. (2005) · CHEST Journal · doi:10.1378/chest.128.5_suppl_1.526s · Cited by 153
CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis
Gharaee‐Kermani, M., McCullumsmith, R. E., Charo, I. F., Kunkel, S. L., & Phan, S. H. (2003) · Cytokine · doi:10.1016/j.cyto.2003.08.003 · Cited by 148
Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease
Tcherakian, C., Cottin, V., Brillet, P.-Y., Freynet, O., Naggara, N., Carton, Z., Cordier, J.-F., Brauner, M., Valeyre, D., & Nunes, H. (2011) · Thorax · doi:10.1136/thx.2010.137190 · Cited by 144
Self-citationA neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Takemasa, A., Ishii, Y., & Fukuda, T. (2012) · European Respiratory Journal · doi:10.1183/09031936.00127011 · Cited by 140
El‐Chemaly, S., Malide, D. A., Zudaire, E., Ikeda, Y., Weinberg, B. A., Pacheco–Rodriguez, G., Rosas, I. O., Aparicio, M. E., Ren, P., MacDonald, S. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813368106 · Cited by 132
Mercer, P. F., Johns, R. H., Scotton, C. J., Krupiczojc, M. A., Königshoff, M., Howell, D. C. J., McAnulty, R. J., Das, A., Thorley, A. J., Tetley, T. D., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1827oc · Cited by 129
Self-citationBlanc‐Brude, O., Archer, F., Leoni, P., Derian, C. K., Bolsover, S., Laurent, G. J., & Chambers, R. C. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.021 · Cited by 119
Self-citationUnbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis
Ruiz, V., Ordóñez, R. M., Berumen, J., Ramírez, R., Uhal, B., Becerril, C., Pardo, A., & Selman, M. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00183.2003 · Cited by 118
Idiopathic Interstitial Pneumonias: Prevalence of Mediastinal Lymph Node Enlargement in 206 Patients
Souza, C. A., Müller, N. L., Lee, K. S., Johkoh, T., Mitsuhiro, H., & Chong, S. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.04.1663 · Cited by 117
Chibbar, R., Shih, F., Båga, M., Torlakovic, E., Ramlall, K., Skomro, R., Cockcroft, D. W., & Lemire, E. G. (2004) · Modern Pathology · doi:10.1038/modpathol.3800149 · Cited by 109
Tsukamoto, K. (2000) · Thorax · doi:10.1136/thorax.55.11.958 · Cited by 102
Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias
Ryu, Y. J., Chung, M. P., Han, J., Kim, T. S., Lee, K. S., Chun, E.-M., Kyung, S. Y., Jeong, S. H., Colby, T. V., Kim, H., et al. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.06.003 · Cited by 99
Epithelial Stress and Apoptosis Underlie Hermansky-Pudlak Syndrome–associated Interstitial Pneumonia
Mahavadi, P., Korfei, M., Henneke, I., Liebisch, G., Schmitz, G., Gochuico, B. R., Markart, P., Bellusci, S., Seeger, W., Ruppert, C., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1414oc · Cited by 98
Interleukin-17–mediated Immunopathogenesis in Experimental Hypersensitivity Pneumonitis
Joshi, A. D., Fong, D. J., Oak, S. R., Trujillo, G., Flaherty, K. R., Martinez, F. J., & Hogaboam, C. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1700oc · Cited by 96
Yogo, Y., Fujishima, S., Inoue, T., Saito, F., Shiomi, T., Yamaguchi, K., & Ishizaka, A. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-80 · Cited by 91
ELMOD2 , a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses
Pulkkinen, V., Bruce, S., Rintahaka, J., Hodgson, U., Laitinen, T., Alenius, H., Kinnula, V. L., Myllarniemi, M., Matikainen, S., & Kere, J. (2010) · The FASEB Journal · doi:10.1096/fj.09-138545 · Cited by 67
Cryptogenic fibrosing alveolitis
Chan‐Yeung, M., & Müller, N. L. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06303-4 · Cited by 65
The role of chemokines and cytokines in lung fibrosis
Keane, M. P. (2008) · European Respiratory Review · doi:10.1183/09059180.00010908 · Cited by 48
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Spitalieri, P., Quitadamo, M. C., Orlandi, A., Guerra, L., Giardina, E., Casavola, V., Novelli, G., Saltini, C., & Sangiuolo, F. C. (2011) · European Respiratory Journal · doi:10.1183/09031936.00005511 · Cited by 45
Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung
Sozio, F., Rossi, A., Weber, E., Abraham, D., Nicholson, A. G., Wells, A. U., Renzoni, E. A., & Sestini, P. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01473.x · Cited by 44
Self-citationTriple therapy in idiopathic pulmonary fibrosis: an alarming press release
Wells, A. U., Behr, J., Costabel, U., Cottin, V., & Poletti, V. E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00009112 · Cited by 44
Self-citationCharacterization of lymphangiogenesis in various stages of idiopathic diffuse alveolar damage
Yamashita, M., Iwama, N., Date, F., Chiba, R., Ebina, M., Miki, H., Yamauchi, K., Sawai, T., Nose, M., Sato, S., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.06.031 · Cited by 42
Capodanno, D., Bhatt, D. L., Goto, S., O’Donoghue, M. L., Moliterno, D. J., Tamburino, C., & Angiolillo, D. J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04869.x · Cited by 41
Cited by
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Autophagy and inflammation in chronic respiratory disease
Racanelli, A. C., Kikkers, S. A., Choi, A. M. K., & Cloonan, S. M. (2018) · Autophagy · doi:10.1080/15548627.2017.1389823 · Cited by 547
“a result, activation of cytokines, chemokines, and growth factors persist and remain unchecked.(94)”
BackgroundCellular interactions in the pathogenesis of interstitial lung diseases
Bagnato, G., & Harari, S. (2015) · European Respiratory Review · doi:10.1183/09059180.00003214 · Cited by 277
Tzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Bouros, E., Oikonomou, A., Zissimopoulos, A., Boussios, N., Dardzinski, B., Gritzalis, D., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-171 · Cited by 255
“As a result, there is no current standard of care for patients with IPF since both the disease and the effort to treat it are moving targets [1,2].”
BackgroundSelf-citationHsu, H.-S., Liu, C.-C., Lin, J.-H., Hsu, T.-W., Hsu, J.-W., Su, K., & Hung, S.-C. (2017) · Scientific Reports · doi:10.1038/s41598-017-14612-5 · Cited by 205
Metadata
- Authors
- Wuyts, W. A., Agostini, C., Antoniou, K. M., Bouros, D., Chambers, R. C., Cottin, V., Egan, J. J., Lambrecht, B. N., Lories, R., Parfrey, H., Prasse, A., Robalo-Cordeiro, C., Verbeken, E., Verschakelen, J. A., Wells, A. U., & Verleden, G. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2012-10-25
- Volume
- 41
- Issue
- 5
- Pages
- 1207-1218
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2150969530
- Cited by
- 356
- References
- 102
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.